EVGN Stock Analysis: Buy, Sell, or Hold?
EVGN - EVOGENE LTD.
$1.00
-0.01 (-0.99%)
▼
5d:
-5.66%
30d:
-9.09%
90d:
-18.7%
HOLD
MODERATE Confidence
Last Updated: February 2, 2026
Earnings: Mar 05, 2026
30d
Get Alerted When EVGN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: EVGN shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: EVGN shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: EVGN is currently trading at $1.00, which is considered oversold relative to its 30-day fair value range of $1.00 to $1.11.
Technical Outlook: Technically, EVGN is in a downtrend. The price is currently testing key support at $1.00. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: EVGN has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $2.50 (+147.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, EVGN is in a downtrend. The price is currently testing key support at $1.00. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: EVGN has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $2.50 (+147.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$1.00 -
$1.11
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 147.5% below Wall St target ($2.50)
- CAUTION: 5-day price weakness (-5.7%) - monitor closely
Fair Price Analysis
30-Day Fair Range
$1.00 -
$1.11
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$1.00
Resistance Level
$1.10
Current Trend
Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
-0.75
Wall Street Target
$2.50
(+147.5%)
Revenue Growth (YoY)
-82.6%
Profit Margin
-34.3%
Last updated: February 02, 2026 1:48 PM ET
Data refreshes hourly during market hours. Next update: 2:48 PM
Data refreshes hourly during market hours. Next update: 2:48 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is EVGN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$404 | 62 BUY |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$64 | 57 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
19 analysts |
$215 | 53 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$8 | 54 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$102 | 60 HOLD |
